Clinical Trial Update: A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 10-week efficacy and safety study of Gabitril (tiagabine) in adults with Generalized Anxiety Diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Gabitril (tiagabine)

Snippet

Sponsor: Cephalon | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED